Crizotinib-induced Rectal Perforation with Abscess.

about

Crizotinib-induced Rectal Perforation with Abscess.

Item

http://www.wikidata.org/entity/Q47114588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Crizotinib-induced Rectal Perforation with Abscess.

@en

Crizotinib-induced Rectal Perforation with Abscess.

@nl

type

Item

label

Crizotinib-induced Rectal Perforation with Abscess.

@en

Crizotinib-induced Rectal Perforation with Abscess.

@nl

prefLabel

Crizotinib-induced Rectal Perforation with Abscess.

@en

Crizotinib-induced Rectal Perforation with Abscess.

@nl

P1476

Crizotinib-induced Rectal Perforation with Abscess.

@en

P2093

Asako Yanagisawa

http://www.w3.org/2001/XMLSchema#string

Hiroshi Tabeta

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Amano

http://www.w3.org/2001/XMLSchema#string

Makoto Nakamura

http://www.w3.org/2001/XMLSchema#string

Noriko Hayama

http://www.w3.org/2001/XMLSchema#string

Satoshi Hirano

http://www.w3.org/2001/XMLSchema#string

Sukeyuki Nakamura

http://www.w3.org/2001/XMLSchema#string

P2860

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Bowel perforation after erlotinib treatment in a patient with non-small cell lung cancer.

Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report

Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer.

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

Gastrointestinal perforations in patients treated with erlotinib: A report of two cases with fatal outcome and literature review.

Correlation of plasma crizotinib trough concentration with adverse events in patients with anaplastic lymphoma kinase positive non-small-cell lung cancer.

Successful treatment with alectinib after crizotinib-induced esophageal ulceration.

P304

3211-3213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2169/INTERNALMEDICINE.8214-16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29021430

http://www.w3.org/2001/XMLSchema#string

P921

crizotinib

P932

5742395

http://www.w3.org/2001/XMLSchema#string